Fingerprint
Dive into the research topics of 'In silico analysis reveals EP300 as a panCancer inhibitor of anti-tumor immune response via metabolic modulation'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
In silico analysis reveals EP300 as a panCancer inhibitor of anti-tumor immune response via metabolic modulation
Rosemarie Krupar*, Christian Watermann, Christian Idel, Julika Ribbat-Idel, Anne Offermann, Helen Pasternack, Jutta Kirfel, Andrew G. Sikora, Sven Perner
*Corresponding author for this work
1
Citation
(Scopus)